| 1 |
29806620 | Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION). | 2018 Aug 27 |
2 |
| 2 |
28090231 | Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study. | 2017 Feb |
1 |
| 3 |
26549210 | SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies. | 2016 |
1 |
| 4 |
24919820 | Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study. | 2015 Mar |
1 |
| 5 |
23276620 | Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus. | 2013 May-Jun |
1 |